Literature DB >> 22190562

Totally drug-resistant tuberculosis in India.

Zarir F Udwadia, Rohit A Amale, Kanchan K Ajbani, Camilla Rodrigues.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22190562     DOI： 10.1093/cid/cir889

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  141 in total

1.  Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.

Authors:  Kanchan Ajbani; Shou-Yean Grace Lin; Camilla Rodrigues; Duylinh Nguyen; Francine Arroyo; Janice Kaping; Lynn Jackson; Richard S Garfein; Donald Catanzaro; Kathleen Eisenach; Thomas C Victor; Valeru Crudu; Maria Tarcela Gler; Nazir Ismail; Edward Desmond; Antonino Catanzaro; Timothy C Rodwell
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Aminoglycoside multiacetylating activity of the enhanced intracellular survival protein from Mycobacterium smegmatis and its inhibition.

Authors:  Wenjing Chen; Keith D Green; Oleg V Tsodikov; Sylvie Garneau-Tsodikova
Journal:  Biochemistry       Date:  2012-06-05       Impact factor: 3.162

3.  Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done.

Authors:  Marco Schito; Markus Maeurer; Peter Kim; Debra Hanna; Alimuddin Zumla
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

4.  Zafirlukast inhibits complexation of Lsr2 with DNA and growth of Mycobacterium tuberculosis.

Authors:  Lucile Pinault; Jeong-Sun Han; Choong-Min Kang; Jimmy Franco; Donald R Ronning
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

5.  Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.

Authors:  Hao Li; Masood ur Rehman Kayani; Yunting Gu; Xiaobo Wang; Ting Zhu; Hongfei Duan; Yifeng Ma; Hairong Huang; Babak Javid
Journal:  J Clin Microbiol       Date:  2015-06-10       Impact factor: 5.948

6.  Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.

Authors:  Sandirai Musuka; Shashikant Srivastava; Chandima Wasana Siyambalapitiyage Dona; Claudia Meek; Richard Leff; Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

7.  Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence.

Authors:  Molly F Franke; Sasha C Appleton; Carole D Mitnick; Jennifer J Furin; Jaime Bayona; Katiuska Chalco; Sonya Shin; Megan Murray; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

8.  An in vivo platform for rapid high-throughput antitubercular drug discovery.

Authors:  Kevin Takaki; Christine L Cosma; Mark A Troll; Lalita Ramakrishnan
Journal:  Cell Rep       Date:  2012-07-20       Impact factor: 9.423

Review 9.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Borna Müller; Sonia Borrell; Graham Rose; Sebastien Gagneux
Journal:  Trends Genet       Date:  2012-12-13       Impact factor: 11.639

10.  Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.

Authors:  G B Migliori; G Sotgiu; N R Gandhi; D Falzon; K DeRiemer; R Centis; M G Hollm-Delgado; D Palmero; C Pérez-Guzmán; M H Vargas; L D'Ambrosio; A Spanevello; M Bauer; E D Chan; H S Schaaf; S Keshavjee; T H Holtz; D Menzies
Journal:  Eur Respir J       Date:  2012-10-11       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.